Collegium Pharmaceutical, Inc Ratios

Ratios Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 87.55%90.89%40.92%34.73%58.01%54.40%45.15%57.55%59.76%
EBT Margin 7,109.92%6,229.16%-5,509.64%-262.91%-13.95%-7.66%8.90%-1.22%-6.22%13.36%15.61%
EBIT Margin 7,009.92%6,129.16%-5,498.66%-264.95%-7.38%-8.00%18.14%6.37%7.18%29.46%26.91%
EBITDA Margin 7,009.92%6,129.16%-5,498.66%-264.95%-7.38%-8.00%18.14%6.37%7.18%29.46%26.91%
Operating Margin 7,009.92%6,129.16%-5,498.66%-264.95%-7.38%-8.00%18.14%6.37%7.18%29.46%26.91%
Net Margin 7,109.92%6,229.16%-5,504.15%-262.91%-13.95%-7.66%8.63%25.83%-7.23%8.12%6.71%
FCF Margin 7,125.00%4,995.22%-4,414.38%-238.83%58.45%7.19%28.51%36.70%26.43%48.40%32.20%
Efficiency
Inventory Average 1.56M4.82M8.73M12.63M16.50M31.95M39.42M33.95M
Assets Average 148.79M213.41M298.77M475.07M667.96M933.10M1,158.72M1,403.45M
Equity Average 119.49M97.83M89.51M136.73M194.48M198.88M195.14M212.14M
Invested Capital 137.57M105.56M93.23M91.27M348.53M346.68M769.84M378.76M293.43M
Asset Utilization Ratio 0.191.310.990.650.410.500.490.45
Leverage & Solvency
Interest Coverage Ratio -70.10-61.29-0.00M-1.03-26.131.950.840.532.002.30
Debt to Equity 0.030.010.130.130.850.542.872.072.69
Debt Ratio 0.030.010.040.040.240.160.480.350.37
Equity Ratio 0.830.770.310.290.290.290.170.170.14
Times Interest Earned -70.10-61.29-0.00M-1.03-26.131.950.840.532.002.30
Valuation
Enterprise Value 568.95M292.24M482.40M424.23M519.97M518.57M459.32M605.18M693.21M761.21M
Market Capitalization 568.95M445.47M601.10M570.86M689.99M692.68M645.74M778.87M1,003.76M923.97M
Return Ratios
Return on Sales 71.10%62.29%-55.10%-2.63%-0.14%-0.08%0.09%0.26%-0.07%0.08%0.07%
Return on Capital Employed -0.64%-0.85%-0.24%0.24%0.05%0.07%0.24%0.19%
Return on Invested Capital 0.25%0.18%0.22%
Return on Assets -0.50%-0.18%-0.08%0.06%0.11%-0.04%0.04%0.03%
Return on Equity -0.63%-0.40%-0.25%0.20%0.37%-0.17%0.24%0.20%